PRDX2 silencing alleviates reactive hyperplasia of Müller glial cells in diabetic retinopathy by inhibiting the RhoA/ROCK signaling pathway

Table 2 Correlation analysis for PRDX2 in patients with diabetes

Variable	Spearman, rs	P value
Age	-0.083	0.278
Females	0.013	0.863
Hypertension	0.038	0.620
FBG	-0.022	0.775
ALT	-0.027	0.728
AST	-0.044	0.582
ALP	0.085	0.287
GGT	-0.138	0.096
TP	-0.051	0.515
Alb	-0.081	0.298
A/G	-0.074	0.345
K	-0.005	0.950
Na	0.056	0.476
Cl	0.075	0.332
P	0.070	0.384
Ca	-0.061	0.442
Urea	0.195	0.011
SUA	0.088	0.264
SCr	0.144	0.061
VEGFA	0.356	< 0.0001
The severity of DR	0.267	< 0.0001

Spearman correlation between plasma PRDX2 levels and non-normally distributed clinical variables in the diabetic cohort. FBG: Fasting blood glucose; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase; TP: Total protein; Alb: Albumin; A/G: Albumin/globulin; SCr: Serum creatinine; SUA: Serum uric acid; VEGFA: Vascular endothelial growth factor A; DR: Diabetic retinopathy.